C Furberg - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C Furberg

Showing results (31-40 of 38) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 38 results.

Annals of Internal Medicine|April 29, 2000

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement StudyD Grady, N K Wenger, D Herrington, et al.

Lakartidningen|November 19, 1975

[The long QT-syndrome]C Furberg, G Heinrich, J Hällén, et al.

Journal of Electrocardiology|January 1, 1993

Improved ECG models for estimation of left ventricular hypertrophy progression and regression incidence by redefinition of the criteria for a significant change in left ventricular hypertrophy status. The MRFIT Research Group. Multiple Risk Factor Intervention TrialS H Zhou, P M Rautaharju, R Prineas, et al.

Circulation|December 1, 1994

Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing GroupT Pearson, E Rapaport, M Criqui, et al.

The American Journal of Cardiology|May 1, 1986

Risk factors, exercise fitness and electrocardiographic response to exercise in 12,866 men at high risk of symptomatic coronary heart diseaseR S Crow, P M Rautaharju, R J Prineas, et al.

Diabetologia|November 25, 2010

Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health StudyT L Nelson, A Kamineni, B Psaty, et al.

Circulation|September 1, 1989

AHA Conference Report on Cholesterol. Intervention studiesR I Levy, D Blankenhorn, C E Davis, et al.

European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 16, 2007

Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases, C Ballantyne, M Cushman, et al.

Pageof 4

Search research articles

Showing results (31-40 of 38) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 38 results.

Annals of Internal Medicine|April 29, 2000

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement StudyD Grady, N K Wenger, D Herrington, et al.

Lakartidningen|November 19, 1975

[The long QT-syndrome]C Furberg, G Heinrich, J Hällén, et al.

Journal of Electrocardiology|January 1, 1993

Circulation|December 1, 1994

The American Journal of Cardiology|May 1, 1986

Risk factors, exercise fitness and electrocardiographic response to exercise in 12,866 men at high risk of symptomatic coronary heart diseaseR S Crow, P M Rautaharju, R J Prineas, et al.

Diabetologia|November 25, 2010

Circulation|September 1, 1989

AHA Conference Report on Cholesterol. Intervention studiesR I Levy, D Blankenhorn, C E Davis, et al.

Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases, C Ballantyne, M Cushman, et al.

Pageof 4